Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Fatma Ümit Malya 1 Article
Cyst Fluid Carcinoembryonic Antigen Level Difference between Mucinous Cystic Neoplasms and Intraductal Papillary Mucinous Neoplasms
Ibrahim Hakkı Köker, Nurcan Ünver, Fatma Ümit Malya, Ömer Uysal, Elmas Biberci Keskin, Hakan Şentürk
Clin Endosc 2021;54(1):113-121.   Published online December 11, 2020
DOI: https://doi.org/10.5946/ce.2020.083
AbstractAbstract PDFPubReaderePub
Background
/Aims: The role of cyst fluid carcinoembryonic antigen (CEA) level in differentiating mucinous pancreatic cystic lesions (PCLs) is controversial. We investigated the role of cyst fluid CEA in differentiating low-risk (LR)-intraductal papillary mucinous neoplasms (IPMNs) from high-risk (HR)-IPMNs and LR-mucinous cystic neoplasms (MCNs).
Methods
This was a retrospective study of 466 patients with PCLs who underwent endoscopic ultrasound-guided fine-needleaspiration over a 7-year period. On histology, low-grade dysplasia and intermediate-grade dysplasia were considered LR, whereas high-grade dysplasia and invasive carcinoma were considered HR.
Results
Data on cyst fluid CEA levels were available for 50/102 mucinous PCLs with definitive diagnoses. The median CEA (range) levels were significantly higher in HR cysts than in LR cysts (2,624 [0.5–266,510] ng/mL vs. 100 [16.8–53,445]ng/mL, p=0.0012). The area under the receiver operating characteristic curve (AUROC) was 0.930 (95% confidence interval [CI], 0.5–0.8; p<0.001) for differentiating LR-IPMNs from LR-MCNs. The AUROC was 0.921 (95% CI, 0.823–1.000; p<0.001) for differentiating LR-IPMNs from HR-IPMNs. Both had a CEA cutoff level of >100ng/mL, with a negative predictive value (NPV) of 100%.
Conclusions
Cyst fluid CEA levels significantly vary between LR-IPMNs, LR-MCNs, and HR-IPMNs. A CEA cutoff level of >100ng/mL had a 100% NPV in differentiating LR-IPMNs from LR-MCNs and HR-IPMNs.

Citations

Citations to this article as recorded by  
  • An Overview for Clinicians on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas
    Dimitrios Moris, Ioannis Liapis, Piyush Gupta, Ioannis A. Ziogas, Georgia-Sofia Karachaliou, Nikolaos Dimitrokallis, Brian Nguyen, Pejman Radkani
    Cancers.2024; 16(22): 3825.     CrossRef
  • Spectrum of MRI Features of Mucin-producing Neoplasms in the Abdomen and Pelvis
    Pei-Kang Wei, Mamta Gupta, Leo L. Tsai, Karen S. Lee, Adrian M. Jaramillo, Martin P. Smith, Jordan D. LeGout, Anuradha S. Shenoy-Bhangle
    RadioGraphics.2022; 42(2): 469.     CrossRef
  • Is Carcinoembryonic Antigen the Holy Grail for Pancreatic Cyst Risk Stratification?
    Ahmad Najdat Bazarbashi, Linda S. Lee
    Clinical Endoscopy.2021; 54(1): 7.     CrossRef
  • Deep Learning-Based Differentiation between Mucinous Cystic Neoplasm and Serous Cystic Neoplasm in the Pancreas Using Endoscopic Ultrasonography
    Leang Sim Nguon, Kangwon Seo, Jung-Hyun Lim, Tae-Jun Song, Sung-Hyun Cho, Jin-Seok Park, Suhyun Park
    Diagnostics.2021; 11(6): 1052.     CrossRef
  • 4,213 View
  • 145 Download
  • 3 Web of Science
  • 4 Crossref
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP